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The present study aimed to investigate the anti-hyperlipidemic effects of sesame in a high-fat fed rabbit model. Animals were
randomly divided into four groups of eight animals each for 60 days as follows: normal diet, hypercholesterolemic diet (1%
cholesterol), hypercholesterolemic diet (1% cholesterol) + sesame seed (10%), and hypercholesterolemic diet (1% cholesterol) +
sesame oil (5%). Serum concentrations of total cholesterol, LDL-C, HDL-C, triglycerides, apoA and apoB, SGOT, SGPT, glucose
and insulin were measured at the end of supplementation period in all studied groups. Hypercholesterolemic feeding resulted
in a significant elevation of TC, TG, LDL-C, HDL-C, SGOT and SGPT as compared to the normocholesterolemic diet group
(𝑃 < 0.05). Supplementation with sesame seed did not cause any significant alteration in lipid profile parameters, apolipoproteins,
hepatic transaminases, glucose and insulin as compared to the hypercholesterolemic diet group (𝑃 > 0.05). In contrast, rabbits
supplemented with sesame oil were found to have lower circulating concentrations of TC, LDL-C, HDL-C, SGOT and SGPT
(𝑃 < 0.05), whilst concentrations of TG, apoA, apoB, insulin and glucose remained unaltered compared to the hypercholesterolemic
diet group (𝑃 > 0.05). Supplementation with sesame oil, but not sesame seed, can ameliorate serum levels of lipids and hepatic
enzymes in rabbits under a high-fat diet.
1. Introduction
Cardiovascular and cerebrovascular diseases are the most
frequent causes of morbidity and mortality in the US and
other western countries [1]. The primary cause of these vas-
cular diseases is atherosclerosis and subsequent formation of
lesions inside the coronary and cerebral arteries [2]. Athero-
genic plaques are formed as a result of accumulation of lipids
and fibrous elements in the subendothelial space of large
arteries. Pathogenesis of atherosclerosis is multifactorial, and
many modifiable and nonmodifiable risk factors have been
identified [3]. These risk factors collectively contribute to
the development, progression, and rupture of atherosclerotic
plaque [4].
Recent decades have seen a rapid rise in reports indicating
that botanical dietary supplements can improve cardiovas-
cular health and prevent from atherosclerosis disease at
several steps [5]. Current research into free radicals has
confirmed that foods rich in antioxidants play an essential
role in the prevention of cardiovascular disease and cancer
[6–8].Therefore, plant derived antioxidants are now receiving
special attention [9, 10]. Sesamum indicum Linn. (sesame)
belongs to the family Pedaliaceae and has been routinely used
for culinary purposes in the oriental cuisine. In addition,
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several lines of evidence from traditional as well as modern
medicine have confirmed various medicinal properties of
sesame [11–13]. This plant possesses significant amounts of
diverse phytochemicals, most importantly phenolic acids and
lignans [14]. Oils and phytochemicals obtained from sesame
have been shown to serve as promising natural antioxidants
for both food preservation and medicinal applications [12].
Sesame seed contains moisture, crude oil, crude proteins,
carbohydrates, crude fiber, and ash. Sesame oil (constituting
∼50% of total seed content) is a rich source of mono-
and polyunsaturated fatty acids [15]. Previous studies have
reported that high antioxidant properties of sesame seed
appear to be related to its main lignans namely sesamol,
sesamolinol, pinoresinol, and sesaminol [16–18] as well as
vitamin E [19]. As key constituents of sesame, lignans, dietary
fibers and, polyunsaturated fatty acids have been reported
to possess antihyperlipidemic and antihyperglycemic effects
[20–22]. However, only a few studies have been conducted to
clarify these pharmacological effects in hypercholesterolemic
models supplemented with sesame powder and sesame oil
[23–26]. Therefore, the present study was designed with the
aim of evaluating the effects of sesame seed and sesame oil
on serum lipids, apolipoproteins, liver enzymes, glucose, and
insulin in a hyperlipidemic rabbit model.
2. Materials and Methods
2.1. Sesame Seed Collection. Sesame seeds were purchased
from a local fruit market in Shahrekord, Iran. Genus and
species of the plant were identified and authenticated by a
plant taxonomist and deposited at the Shahrekord University
of Medical Sciences (Shahrekord, Iran, herbarium no. 409).
Sesameoil wasmechanically extracted using a screwpress (oil
expeller) as commonly used and described elsewhere [27].
2.2. Phytochemical Analysis. Total phenolic and total fla-
vonoid contents of sesame seed and sesame oil were colori-
metrically determined using Folin-Ciocalteu and aluminium
chloride reagents, respectively [25, 28, 29]. Total values of
phenolics and flavonoids were expressed in terms of gallic
acid equivalent (GAE) and rutin equivalent (RE) (in mg/g),
respectively.
2.3. Grouping and Treatments. Thirty-two adult male rabbits
of New Zealand strain weighing 1.25–2.50 kg were purchased
from the Razi Institute (Karaj, Iran). Rabbits weremaintained
in animal stainless steel mesh-bottomed cages at the Medici-
nal Plants ResearchCenter, ShahrekordUniversity ofMedical
Sciences (Shahrekord, Iran), for two weeks at 21–24∘C and
12 h light:dark cycle. Animals were fed a standard basal diet
for 2 weeks for adaptation. Following the initial two weeks,
nourishment was done by standard grain food purchased
from Pars Animal Feed Company (Tehran, Iran), containing
15% protein, 40–50% carbohydrates, 2% vegetable fat, and 15–
25% fiber. Animals were randomly divided into four groups
of eight animals each to be fed with normal diet, hypercholes-
terolemic diet (1% cholesterol), hypercholesterolemic diet
(1% cholesterol) + sesame seed (10%), or hypercholes-
terolemic diet (1% cholesterol) + sesame oil (5%).
The study protocol was approved by the Medical Ethics
Committee of the Isfahan Cardiovascular Research Center.
2.4. Biochemical Measurements. Fasted blood samples were
collected to determine serum concentrations of lipid parame-
ters (comprising total cholesterol (TC), high-density lipopro-
tein cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), and triglycerides (TG)), liver enzymes (comprising
serum glutamate oxaloacetate transaminase (SGOT) and
serum glutamate pyruvate transaminase (SGPT)), insulin,
glucose, and apolipoproteins A (apo A) and B (apo B). Serum
insulin level was determined with an ELISA method using a
commercial kit (Monobind Inc., CA, USA). Other evaluated
biochemical factors were measured by routine enzymatic
methods using commercial kits (Pars Azmoon, Tehran, Iran)
on a Hitachi 902 autoanalyzer (Tokyo, Japan).
2.5. Statistical Analysis. Statistical analyses were conducted
using SPSS software version 13.0 (SPSS Inc., Chicago, IL,
USA). Between-group comparisons of biochemical factors
were carried out using Kruskal-Wallis test. Post-hoc multiple
comparisons were made using Dunn’s test. A 𝑃 value of <0.05
was considered as statistically significant.
3. Results
Phytochemical investigations on sesame seed powder
revealed total phenolics, flavonoids, and flavonols to be 30.1,
84.1, and 68.7mg/g, respectively. As for the sesame oil, the
values were 17.2, 52 and 47.8mg/g, respectively.
Feeding rabbits with a hypercholesterolemic diet con-
taining 1% cholesterol for 8 weeks resulted in a significant
elevation of TC, TG, LDL-C, HDL-C, SGOT, and SGPT as
compared to the normocholesterolemic diet group (𝑃 <
0.05) (Tables 1 and 2). In contrast, serum concentrations
of HDL-C, glucose, insulin, apo A, and apo B remained
statistically unchanged between hypercholesterolemic and
normocholesterolemic diet groups (𝑃 > 0.05) (Tables 1 and
2).
Supplementation with sesame seed (10%) did not cause
any significant alteration in lipid profile parameters, apol-
ipoproteins, hepatic transaminases, glucose, and insulin as
compared to the hypercholesterolemic diet group (𝑃 > 0.05).
In comparison with the normocholesterolemic diet group,
serum levels of TC, LDL-C, SGOT, andHDL-Cwere elevated
in the sesame seed containing diet group (𝑃 > 0.05).
Rabbits supplemented with sesame oil (5%) were found to
have lower circulating concentrations of TC, LDL-C, HDL-
C, SGOT, and SGPT (𝑃 < 0.05), whilst concentrations of
TG, apo A, apo B, insulin, and glucose remained unaltered
compared to the hypercholesterolemic diet group (𝑃 > 0.05).
Comparison of sesame oil versus normocholesterolemic diet
groups revealed an elevation of triglycerides and reduction
in apo A concentrations in the sesame oil fed group (𝑃 <
0.05). None of the evaluated biochemical parameters did
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Table 1: Effects of Sesamum indicum on serum concentrations of lipid profile parameters and apolipoprotein in experimental groups.
Biochemical factor Normal diet Hypercholesterolemicdiet (1% cholesterol)
Hypercholesterolemic diet
(1% cholesterol) + sesame
seed (10%)
Hypercholesterolemic diet
(1% cholesterol) + sesame
oil (5%)
Total cholesterol (mg/dL) 178 ± 19.889 2649 ± 610.58a 2045 ± 567.04a 1367 ± 503.00b
Triglyceride (mg/dL) 219 ± 54.488 1270 ± 651.77a 787 ± 280.30 1391 ± 386.00a
Low-density lipoprotein (mg/dL) 101 ± 10.909 1337 ± 546.05a 1279 ± 543.53a 570 ± 446.93b
High-density lipoprotein (mg/dL) 42 ± 2.754 1070 ± 292.45a 630 ± 59.711a 410 ± 95.394b
Apo lipoprotein A (mg/dL) 55 ± 3.697 39 ± 13.371 45 ± 12.703 36 ± 8.192a
Apo lipoprotein B (mg/dL) 24 ± 5.315 31 ± 10.068 29 ± 16.906 27 ± 6.595
aSignificant difference with the normal diet group (𝑃 < 0.05).
bSignificant difference with the hypercholesterolemic diet group (𝑃 < 0.05).
Table 2: Effects of Sesamum indicum on serum concentrations of liver enzymes, glucose, and insulin in experimental groups.
Biochemical factor Normal diet Hypercholesterolemicdiet (1% cholesterol)
Hypercholesterolemic diet
(1% cholesterol) + sesame
seed (10%)
Hypercholesterolemic diet
(1% cholesterol) + sesame
oil (5%)
SGOT (U/L) 33 ± 3.096 105 ± 32.780a 92 ± 55.435a 58 ± 14.125b
SGPT (U/L) 40 ± 5.099 91 ± 18.924a 46 ± 28.849 56 ± 18.026b
Glucose (mg/dL) 132 ± 33.340 147 ± 74.637 151 ± 17.213 150 ± 40.329
Insulin (pmol/L) 26 ± 25.891 27 ± 5.935 27 ± 1.716 32 ± 830.39
SGOT: serum glutamate oxaloacetate transaminase; SGPT: serum glutamate pyruvate transaminase.
aSignificant difference with the normal diet group (𝑃 < 0.05).
bSignificant difference with the hypercholesterolemic diet group (𝑃 < 0.05).
significantly differ between sesame seed and sesame oil
supplemented groups (𝑃 > 0.05).
4. Discussion
Findings of the present study suggested that dietary sup-
plementation with sesame oil significantly reduces TC and
LDL-C concentrations in rabbits under a lipogenic diet.
These findings are consistent with those of previous studies.
Visavadiya and Narasimhacharya [30] examined the effects
of supplementation with sesame seed powder at 5% and
10% doses along with either normal or hypercholesterolemic
diet for a period of 4 weeks. Administration of sesame seed
powder to hypercholesterolemic rats resulted in a significant
decline in plasma and hepatic total lipid and cholesterol, and
plasma LDL-C whilst increasing HDL-C concentrations. In
another investigation to evaluate hypocholesterolemic and
antioxidant activity of sesame protein isolate, Biswas et al. [31]
fed 18% sesame protein isolate with or without 2% cholesterol
in comparison with casein to rats for 28 days. The results
revealed that dietary sesame protein isolate reduces plasma
total cholesterol, triacylglycerol, and LDL-C, increases HDL-
C, and mitigates lipid peroxidation in both hypercholes-
terolemia and normocholesterolemic diet groups. Sirato-
Yasumoto and associates demonstrated that supplementation
with lignan-rich sesame has a remarkable potentiating effect
on hepatic fatty acid oxidation while downregulating the
activity of lipogenic enzymes. These favorable metabolic
effects of lignan-rich sesame were reported to be accom-
panied with a profound hypotriglyceridemic effect [32]. In
a recent report, Asgari et al. [25] investigated the protective
effects of sesame on postprandial lipemic and glycemic
response as well as circulating concentrations of endothelial
function biomarkers in hypercholesterolemic rabbits. Their
results revealed that sesame supplementation is associated
with significant declines in serum TC, LDL-C, SGPT, and
fibrinogen. In the study by Kumar et al. [33], the hep-
atoprotective activity of ethanolic extracts of sesame seeds
(400mg/kg and 700mg/kg orally, once daily) were evaluated
against carbon tetrachloride (CCL
4
)-induced hepatotoxicity
in rats.The authors reported that substantially elevated serum
enzymatic activities of SGOT and SGPT were significantly
restored towards normalization by the extract. The results of
this latter study strongly indicate that sesame seed extract
has potent hepatoprotective effects against CCL
4
-induced
hepatic damage in rats. These antihyperlipidemic effects of
sesame oil could be attributed to the induction of cholesterol
turnover via increasing fecal sterol excretion and hepatic bile
acid production.Moreover, supplementationwith sesame has
been shown to improve antioxidant capacity through pro-
moting hepatic catalase and superoxide dismutase activities
[34].
Sesame contains a diversity of phytochemicals including
lignans, polyphenolic and flavonoid compounds, dietary
fibers, PUFA, and lecithin, which all possess documented
antihyperlipidemic functions [21, 22, 30]. Different lignan
derivatives of sesame such as sesamin, sesamol, sesaminol,
sesaminolinol, and pinoresinol possess antioxidant functions
and can prevent against membrane lipid peroxidation, ADP-
Fe3+/NADPH-induced microsomal lipid peroxidation and
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Cu2+-induced LDL oxidation [35, 36] Furthermore, vitamin
E and flavonoids that naturally occur in sesame have been
reported to possess antioxidant and lipid-lowering properties
[20, 31, 37, 38]. Sesamin is one of the most important
lignan components of sesame seeds. This phytochemical has
been reported to exert hypocholesterolemic effects through
inhibition of the intestinal absorption of cholesterol, increase
of biliary cholesterol excretion, and downregulation of 3-
hydroxy-3-methylglutaryl coenzyme A reductase activity
[39]. Aside from the aforementioned effects, sesamin has
promising antioxidant properties which are, at least in
part, due to the inhibition of tocopherol catabolism and
enhancement of circulating as well as tissue concentrations
of tocopherols [40]. The higher antihyperlipidemic activity
of sesame oil versus sesame seed that was observed in the
present study is most likely due to the higher frequencies
of the aforementioned phytonutrients in the oil due to their
lipophilic characteristics.
5. Conclusions
In summary, findings arising from the present study revealed
a trend towards amelioration of lipid profile and hepatic
enzymes following supplementation with sesame oil (5%).
These positive effects of sesame oil further corroborate
previous findings and jointly postulate therapeutic value of
sesame oil as a safe and effective supplement for patients
with dyslipidemia or nonalcoholic fatty liver disease. Future
research should concentrate on the exact mechanisms under-
lying the antihyperlipidemic effects and also further explore
whether these effects are exerted by a single constituent or are
due to a synergism between different phytochemicals.
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